Pharmacosmos has launched Uniferon^®, the industry-leading injectable iron supplement, in Poland's pig market.

A recent introduction of the industry-leading injectable iron supplement Uniferon to pig producers in Poland paves the way for even more competitiveness for the Polish pig farmers. The introduction is furthermore another significant step for Pharmacosmos, the Danish pharmaceutical company that has developed and produces Uniferon.

"Having Uniferon in Poland is a great opportunity to give our piglets the best quality iron available. The decline in pig production and pig population in Poland has made the market even more competitive. Facing this, farmers are looking for the best available management and supplementation of their herds to bring the best possible products to the market. We believe Uniferon to be a very promising product as it meets the farmers' needs and expectations," said Tomasz Paluch from Vetoquinol in Poland.

Pharmacosmos develops and markets medicines for the treatment of iron deficiency. A research-based company, its on-going R&D programme focuses on improving the treatment options for healthcare professionals, patients suffering from iron deficiency and veterinary treatments.